Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.
about
Evolution of management in peritoneal surface malignanciesTreatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectivesAdhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic optionsImpact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusionPalliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer?Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selectionMultimodality treatment strategies have changed prognosis of peritoneal metastasesAbdominal metastases from colorectal cancer: intraperitoneal therapyTreatment of peritoneal metastases from colorectal cancerRole of multi-modality therapy in peritoneal carcinomatosis and visceral metastasis: a case report and review of the literatureLooking up: Recent advances in understanding and treating peritoneal carcinomatosisTherapeutic options for peritoneal metastasis arising from colorectal cancerHyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal CarcinomatosisSystematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosisStrategies to prevent peritoneal carcinomatosis arising from colorectal cancer.A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal carcinomatosisMetastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapyPhase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer.Current treatment options for colon cancer peritoneal carcinomatosis.Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies.Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis.A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trialGastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumabIntraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review.BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis.Preliminary Experience and Morbidity Analysis of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) from a Tertiary Cancer Center in India.Nomograms to predict survival after colorectal cancer resection without preoperative therapy.Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin.Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstructionPatients at risk for peritoneal surface malignancy of colorectal cancer origin: the role of second look laparotomyCytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal CancerMolecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites.A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion.Impact of hyperthermic intraperitoneal chemotherapy on Hsp27 protein expression in serum of patients with peritoneal carcinomatosis.Bowel strangulation caused by massive intraperitoneal adhesion due to effective chemotherapy for multiple peritoneal metastases originating from descending colon cancerCytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal and hepatic metastases: a case-control study.Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocolOutcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis.
P2860
Q26741293-C4503A04-AFA8-45FD-A969-3A9AE685AFB8Q26744031-969993C0-C182-4EBB-89C5-865337DB95D3Q26748666-510630C6-FD6D-44DA-B603-49CC2992C497Q26768302-8D3CFFB9-E9B4-43F2-AFA1-507841613420Q26768306-2CC63899-15FC-437B-8CFA-678381A08721Q26768376-AE0AEA26-5D4F-4B86-A2E6-098B73B10CCEQ26769938-C4D628B7-8A12-4CE3-933B-2EC30296D5FCQ26772268-E291E5B1-F1FC-4192-B833-39319F03B0B4Q26783662-56ABE852-7CF7-40F9-9ECE-DBEA21357B41Q26799152-49483D2B-2BFA-437B-B68A-44149C120B40Q26849259-AD9962BC-9763-43D8-9CF3-2D34D4D408A1Q28067123-6A988EAB-AA16-4187-AED4-909DD92C9165Q28077394-499D40B6-0EBB-4EFB-959C-454AA8E695C7Q29994639-AE9DBF15-5C97-41B1-B009-A0639D70C40DQ30239825-DC377F0F-4280-4CB9-A625-493694B312B7Q33418461-B6BFC942-37EC-4399-8224-83847D2BA520Q33850248-DF8F4C93-C6DF-45EF-BC72-0D21B62AD311Q33940841-7E06BE4B-9526-48BA-ACEC-753349DE0B8CQ34207816-8E8308F9-AB5C-41A4-8937-6207DDC434E0Q34362289-661BA293-4F58-4FB9-9F53-0B8C34326ED2Q34477640-F15BA1B4-2F1C-4E69-9859-4F0198DD83D8Q34491336-C434CA56-4742-4BFE-AE40-9DFC8892CA9AQ34580450-6E353CF1-E48F-46FB-98DC-ACF661CE32C0Q35567689-5B7E9462-1909-46B5-987F-2A888AD699D5Q35678364-2A051224-89A9-49AE-B65C-01919B75BBB4Q35870363-43F8EAA1-E255-423F-9F4C-6720CBCFB3B6Q35918268-68EBFBCD-E7F2-40A4-A717-E48DD1165F80Q36110653-BABE4FF0-BE82-42E8-85D0-2FE079E856E8Q36388283-DE9210C4-59E5-4119-BFBD-360EC2BBC357Q36528359-D09C87DA-83AA-47B6-98D6-0B427B2B624BQ36646562-9A52A851-A34A-40EC-89E4-1FEF43CAC434Q36758936-0BC1F0A1-A65E-44EC-A11F-D9B00AFA5A9FQ36843773-FDCBDEF0-0707-470A-AAA7-7AFB2F68D8E5Q36977424-C51F1858-F88A-4C9F-9E39-F996A1122CE5Q37099476-7903F249-3BFD-4554-931E-D0296490D19BQ37280394-ACBDDFA4-B75A-4A4D-9C7C-921D9E81DF74Q37285937-2CF687CA-595D-4C0A-8F94-06962E8C577DQ37308110-3BCDF1C3-BF18-418F-84D1-5689D37A32A7Q37512841-837F4878-87F1-4E7E-BB6E-D9EBD675BC75Q37530472-7F0B66AE-2D79-4DC1-B8F1-35A51D518327
P2860
Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Treatment of colorectal perito ...... se III trials N9741 and N9841.
@ast
Treatment of colorectal perito ...... se III trials N9741 and N9841.
@en
type
label
Treatment of colorectal perito ...... se III trials N9741 and N9841.
@ast
Treatment of colorectal perito ...... se III trials N9741 and N9841.
@en
prefLabel
Treatment of colorectal perito ...... se III trials N9741 and N9841.
@ast
Treatment of colorectal perito ...... se III trials N9741 and N9841.
@en
P2093
P2860
P356
P1476
Treatment of colorectal perito ...... ase III trials N9741 and N9841
@en
P2093
Axel Grothey
Barbara A Pockaj
Charles D Goldman
Garth D Nelson
Henry C Pitot
Jan Franko
Richard M Goldberg
Steven R Alberts
P2860
P304
P356
10.1200/JCO.2011.37.1039
P407
P577
2011-12-12T00:00:00Z